4//SEC Filing
Kearns Evan 4
Accession 0001193125-25-337052
CIK 0001622229other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:01 PM ET
Size
5.3 KB
Accession
0001193125-25-337052
Insider Transaction Report
Form 4
Kearns Evan
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-12-26$38.70/sh−65,000$2,515,500→ 109,398 total
Footnotes (2)
- [F1]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.52 to $38.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001745285
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 4:01 PM ET
- Size
- 5.3 KB